WallStreetZenWallStreetZen

NYSE: CBT
Cabot Corp Earnings & Revenue

CBT past earnings growth

How has CBT's earnings growth performed historically?
Company
41.61%
Industry
7.11%
Market
128.4%
CBT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CBT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CBT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CBT past revenue growth

How has CBT's revenue growth performed historically?
Company
-8.19%
Industry
-3.22%
Market
19.5%
CBT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CBT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CBT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CBT earnings and revenue history

Current Revenue
$3.9B
Current Earnings
$450.0M
Current Profit Margin
11.5%
CBT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CBT Return on Equity

Current Company
35.4%
Current Industry
19.5%
Current Market
28.2%
CBT's Return on Equity (35.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CBT announces earnings.

CBT Return on Assets

Current Company
12.6%
Current Industry
6.2%
CBT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CBT Return on Capital Employed

Current Company
18.83%
Current Industry
11.3%
CBT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CBT vs Specialty Chemical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CBT$3.91B$693.00M$450.00M+3.02%+12.25%
BCPC$929.56M$222.40M$114.82M+7.77%+8.15%
NEU$2.69B$627.25M$399.01M+3.77%+14.88%
OLN$6.62B$1.14B$352.50M-0.49%+6.45%
ASH$2.11B$339.00M$192.00M-3.92%+26.90%

CBT earnings dates

Next earnings date
Aug 5, 2024

Cabot Earnings & Revenue FAQ

What were CBT's earnings last quarter?

On Invalid Date, Cabot (NYSE: CBT) reported Q1 2024 earnings per share (EPS) of $1.50, up 14.5% year over year. Total Cabot earnings for the quarter were $84.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $1.31.

If you're new to stock investing, here's how to buy Cabot stock.

What was CBT's earnings growth in the past year?

As of Q3 2024, Cabot's earnings has grown 41.61% year over year. This is 34.5 percentage points higher than the US Specialty Chemicals industry earnings growth rate of 7.11%. Cabot's earnings in the past year totalled $450.00 million.

What is CBT's earnings date?

Cabot's earnings date is Invalid Date. Add CBT to your watchlist to be reminded of CBT's next earnings announcement.

What was CBT's revenue last quarter?

On Invalid Date, Cabot (NYSE: CBT) reported Q1 2024 revenue of $1.02 billion up 1.36% year over year. In the same quarter last year, Cabot's revenue was $1.03 billion.

What was CBT's revenue growth in the past year?

As of Q3 2024, Cabot's revenue has grown -8.19% year over year. This is 4.98 percentage points lower than the US Specialty Chemicals industry revenue growth rate of -3.22%. Cabot's revenue in the past year totalled $3.91 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.